CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474671997
- Phone
- 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- 4 Shares withheld for taxes Chief Science Officer gave up 2,131 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 7,001 shares (to pay taxes)
- 4 Option exercise Chief Financial Officer acquired 5,023 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 270,270 shares at $0.37 ($100,000)
- 4 Open-market buy CEO and President bought 675,675 shares at $0.37 ($250,000)
- 4 Shares withheld for taxes Chief Science Officer gave up 693 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 203 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 406 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO and President gave up 240 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Science Officer gave up 524 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,053 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 2,190 shares (to pay taxes)
Page 2 of 8 · 143 filings